|
| 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one Basic information |
Product Name: | 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one | Synonyms: | 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one;1,2,4-Triazolo[4,3-a]pyrazin-8(5H)-one, 6,7-dihydro-3-(trifluoromethyl)-;Sitagliptin Impurity 114;3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-
a]pyrazin-8-one;3-(trifluoromethyl)-6,7-dihydro-[l,2,4]triazolo[4,3-a]pyrazin-8(5H)-one;3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one? (Sitagliptin Impurity) | CAS: | 877402-45-4 | MF: | C6H5F3N4O | MW: | 206.13 | EINECS: | | Product Categories: | | Mol File: | 877402-45-4.mol | |
| 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one Chemical Properties |
density | 1.90±0.1 g/cm3(Predicted) | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 12.69±0.20(Predicted) | form | Solid | color | Off-White to Light Grey |
| 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one Usage And Synthesis |
Uses | 3-(Trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one is an intermediate in the synthesis of Sitagliptin Triazecine Analog (S491015). Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes. |
| 3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one Preparation Products And Raw materials |
|